Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06499220 · ClinicalTrials.gov registry record · NA
Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)
A NA study of Chronic Pain, sponsored by MedtronicNeuro.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 10
- Study locations
NCT06499220: Completed NA study of Chronic Pain, sponsored by MedtronicNeuro.
NCT06499220 is a NA study of Chronic Pain that has completed, run by MedtronicNeuro. The registered enrollment target is 201 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower). The trial reports 10 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06499220, a NA study of Chronic Pain, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 10
- Study locations
Study Summary
This is a prospective, multi-center, non-significant risk IDE study of evoked waveforms resulting from stimulation of the dorsal column using a closed-loop system. comprised of Medtronic hardware or off the shelf hardware, which uses recorded waveforms to adjust stimulation amplitude.
Primary Outcome
The ECAP data collected is prototype system/device information for development of a closed loop system.
Conditions Studied
Interventions
- DEVICE Spinal Cord Stimulator
Study Locations (10)
Minnesota
- Nura Research Institute - Edina
- Twin Cities Pain Clinic - Edina
- iSpine Pain Physicians - Maple Grove
Ohio
- The Ohio State University Wexner Medical Center - Columbus
- Kettering Health - Kettering
- Premier Pain Treatment Institute - Mount Orab
California
- Coastal Pain and Spinal Diagnostics - Carlsbad
Iowa
- MercyOne Des Moines Medical Center - Des Moines
Pennsylvania
- Center for Interventional Pain and Spine - Lancaster
West Virginia
- Rockefeller Neuroscience Institute West Virginia University - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2019-10-30 |
| Est. Completion | 2023-10-16 |
| Phase | NA |
What the finished NCT06499220 record still lists
NCT06499220 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulator is the first listed.
NCT06499220 lists 10 locations in 6 states (Minnesota, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT06499220 about?
NCT06499220 is a clinical study titled "Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)". This is a prospective, multi-center, non-significant risk IDE study of evoked waveforms resulting from stimulation of the dorsal column using a closed-loop system. comprised of Medtronic hardware or off the shelf hardware, which uses recorded waveforms to adjust stimulation amplitude.
What is the current status of trial NCT06499220?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2019-10-30. Estimated completion is 2023-10-16.
What conditions does trial NCT06499220 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06499220?
The interventions under investigation include: Spinal Cord Stimulator (DEVICE).
Who is sponsoring clinical trial NCT06499220?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06499220 being conducted?
This trial has 10 study locations across California, Iowa, Minnesota, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06499220's enrollment target sits among peer trials
201 82nd of 301 higher than 220 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI